ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer
Aging and disease · 2023
DOI: 10.14336/ad.2023.1109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging and disease, 2023. Verfasst von Pawel Kordowitzki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preclinical and Basic Sciences, Nicolaus Copernicus University, Torun, Poland. Hauptthemen laut MEDLINE: Endometriosis, Ovarian Neoplasms, Transcription Factors, DNA-Binding Proteins. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Preclinical and Basic Sciences, Nicolaus Copernicus University, Torun, Poland.
- Department of Gynecology including Center of Oncological Surgery (CVK) and Department of Gynecology (CBF), European Competence Center for Ovarian Cancer, Charite, Berlin, Germany.
Zitieren
APA
Kordowitzki, P., Mechsner, S., & Sehouli, J. (2023). ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer. Aging and disease. https://doi.org/10.14336/ad.2023.1109
Vancouver
Kordowitzki P, Mechsner S, Sehouli J. ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer. Aging and disease. 2023. doi:10.14336/ad.2023.1109
BibTeX
@article{Kordowitzki2023,
author = {Kordowitzki, Pawel and Mechsner, Sylvia and Sehouli, Jalid},
title = {ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer},
journal = {Aging and disease},
year = {2023},
doi = {10.14336/ad.2023.1109}
}
EUVIMED